Giant cell arteritis Clinical Trials EU — 13 Studies

Filter these 13 trials by phase, country, sponsor and more.

Open in Search →

FAPI-PET for GPSD Pending

2024-511977-31-01 4 "giant cell arteritis - polymyalgia rheumatica spectrum disea"
A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART) Pending

2024-515287-31-00 5 "Giant Cell Arteritis"
Bosentan in the treatment of Giant Cell Arteritis Pending

2024-517030-17-00 4 "Newly diagnosed or relapsing Giant-cell arteritis"
Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on … Pending

2024-518191-31-00 6 "Inflammatory rheumatic disease"
A randomized trial comparing efficacy and safety of etanercept and methotrexate in giant cell arteritis (EFFECTA) Recruiting

2023-506623-29-01 4 2025-03-12
TocilizuMab discontinuAtion in GIant Cell Arteritis Recruitment ended

2023-505515-21-00 5 2024-04-02 "Giant Cell Arteritis"
MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial Recruitment ended

2024-512269-14-00 5 2020-01-27 "GIant cell Arteritis"
Study to evaluate the pharmacokinetics, safety and tolerability of Secukinumab in patients with GCA or PMR Ended

2023-507667-19-00 3 2024-06-06 "Polymyalgia rheumatica (PMR)"
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Methotrexate as Remission Maintenance Thera … Ended

2022-501058-12-00 4 2022-11-23
Efficacy and Safety of secukinumab in patients with new onset of giant cell arteritis who are in clinical remission Ended

2024-512856-40-00 5 2022-09-21 "Giant Cell Arteritis"
Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Gia … Ended

2024-510744-31-00 5 2021-10-06 "Giant cell arteritis (GCA)"
Efficacy of Tocilizumab in association to steroids in giant cell arteritis with cerebro-vascular involvement patients (ToGiAS). A french pro … Ended

2024-511906-21-00 5 2021-09-24 "Giant cell arteritis with Cerebro-vascular involvement"
A safety and efficacy study of ABT-494 in subjects with Giant Cell Arteritis. Ended

2023-505476-29-00 5 2019-04-05 "Giant Cell Arteritis"

Showing 1–13 of 13 trials